This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

APO-RANITIDINE TABLET 150MG

APOTEX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-RANITIDINE TABLET 150MG in Canada?

Yes. APO-RANITIDINE TABLET 150MG has an active shortage reported to Health Canada (last updated September 18, 2019).

Why is APO-RANITIDINE TABLET 150MG not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-RANITIDINE TABLET 150MG be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength150MG

Last updated2019-02-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

RATIO-RANITIDINE

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

150MG · DIN 00828823

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ZANTAC TAB 150MG

GLAXO CANADA INC

150MG · DIN 00553379

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

NU-RANIT TAB 150MG

NU-PHARM INC

150MG · DIN 00865737

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MED RANITIDINE TABLETS 150MG

MEDICAN PHARMA INCORPORATED

150MG · DIN 02219077

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ZANTAC-C CAP 150MG

GLAXO CANADA INC

150MG · DIN 00849421

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

ZANTAC-C CAP 300MG

GLAXO CANADA INC

300MG · DIN 00849448

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00733059

Strength

150MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

RANITIDINE

Tier

Unrated

Last Updated

2019-02-13

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-RANITIDINE TABLET 150MG has 4 shortage/discontinuation reports on file — this is one of them.

2019-09-18

Active Shortage

Disruption of the manufacture of the drug.

2019-01-09

Permanently Discontinued

Business reasons

2018-12-28

Permanently Discontinued

Business reasons

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244